CSIMarket
 
West Pharmaceutical Services Inc   (NYSE: WST)
 
Price: $342.7300 $0.10 0.029%
Day's High: $345.5 Week Perf: 1.56 %
Day's Low: $ 338.45 30 Day Perf: 0.92 %
Volume (M): 241,438 52 Wk High: $ 386.00
Volume (M$): $ 0 52 Wk Avg: $287.23
Open: $343.97 52 Wk Low: $223.83



 Market Capitalization (Millions $) 24,437
 Shares Outstanding (Millions) 71
 Employees 10,800
 Revenues (TTM) (Millions $) 3,327
 Net Income (TTM) (Millions $) 565
 Cash Flow (TTM) (Millions $) 12
 Capital Exp. (TTM) (Millions $) 225

Business Description


West Pharmaceutical Services, Inc. is a prominent player in the global healthcare and pharmaceutical sectors, specializing in the development and manufacture of innovative packaging components and delivery systems for injectable drugs and medical products. Headquartered in Exton, Pennsylvania, the company has a rich history dating back to its incorporation in 1923, reflecting a longstanding commitment to advancing injectable drug delivery solutions.

Key Products and Services

Wests comprehensive product portfolio includes:

1. Vial Containment Solutions: These are designed to safeguard pharmaceuticals from contamination and ensure safe storage and dispensing.

2. Prefillable Systems: West offers prefilled syringes and associated components that enhance convenience and accuracy in drug delivery, catering specifically to biologics and other sensitive pharmaceuticals.

3. Self-Injection Platforms: This range allows patients to administer their medications independently, providing greater flexibility and control over their healthcare.

4. Cartridge Systems: These systems facilitate the safe and efficient delivery of medications, often used in conjunction with pen injectors and other delivery devices.

5. Reconstitution and Transfer Systems: West provides solutions for effectively mixing and transferring medications, particularly important for lyophilized drugs that require a reconstitution step before administration.

6. Intradermal Delivery Solutions: Innovative systems that allow for targeted delivery of medications to the skin or dermal layers, addressing specific therapeutic needs.

Specialty Components: These products are designed for unique applications within the pharmaceutical industry, tailored to meet specific client requirements.

8. Contract Manufacturing and Analytical Services: West offers these services to support clients in producing high-quality drug delivery systems, ensuring regulatory compliance and meeting stringent industry standards.

Customer Base

West Pharmaceutical Services serves a diverse and distinguished clientele, including leading companies in the biotechnology, generic drugs, pharmaceutical, diagnostics, and medical device sectors. This extensive customer base highlights Wests pivotal role in the pharmaceutical supply chain, contributing to advancements in drug delivery and patient care.

Global Presence

West operates numerous facilities around the globe, reinforcing its ability to meet worldwide demand and support multinational pharmaceutical companies. This global footprint also enables the company to leverage various regional markets’ opportunities while adhering to local regulatory environments.

Commitment to Innovation

The company invests significantly in research and development to drive innovation in its product offerings, focusing on enhancing the safety, efficiency, and ease of use in drug delivery systems. This commitment positions West at the forefront of the industry, helping to address evolving healthcare needs and improving patient outcomes.

Recent Developments

In recent years, West has continued to expand its capabilities and product offerings to adapt to changing market demands, such as the increased focus on biologics and biosimilars. This has included partnerships, collaborations, and strategic investments aimed at elevating their technology and product innovation.

Conclusion

West Pharmaceutical Services, Inc. stands out as a crucial entity in the manufacturing and development of packaging components and delivery systems essential for modern healthcare. With decades of expertise, a commitment to quality, and a broad array of innovative solutions, West remains dedicated to advancing the pharmaceutical and biotechnology industries.


   Company Address: 530 Herman O. West Drive Exton 19341 PA
   Company Phone Number: 594-2900   Stock Exchange / Ticker: NYSE WST


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BLCO        5.9% 
EYE   -5.6%    
MDT        3.48% 
MLSS   -8.06%    
STAA        5.29% 
SYK   -4.39%    
• View Complete Report
   



Stocks on the Move

Challenges and Headwinds Analyzing West Pharmaceutical Services Inc.s Recent Sell-Off and Second-Quarter Performance Results,

Published Wed, Aug 21 2024 10:41 AM UTC

West Pharmaceutical Services: A Closer Look at the Recent Sell-Off and Second Quarter Performance ResultsIn recent news, West Pharmaceutical Services Inc. (NYSE: WST) has faced significant challenges in the stock market, underperforming its competitors and experiencing a decrease in profits and revenues in the second quarter of 2024. With a 52-week high of $415.73, the stock...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 43.88
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 7.35
Price to Sales (Expected) -
Price to Book 8.17
PEG (TTM) 2.57

Financial Strength Current
Quick Ratio 0.68
Working Capital Ratio 2.5
Leverage Ratio (MRQ) 0.36
Total Debt to Equity 0.07
Interest Coverage (TTM) -
Debt Coverage (TTM) 4.32

Per Share Current
Earnings (TTM) 7.81 $
Revenues (TTM) 46.66 $
Cash Flow (TTM) 0.16 $
Cash 6.11 $
Book Value 41.94 $
Dividend (TTM) 0.87 $

Efficiency Current
Revenue per Employee (TTM) 308,046
Net Income per Employee (TTM) 52,306
Receivable Turnover Ratio (TTM) 5.12
Inventory Turnover Ratio (TTM) 4.72
Asset Turnover Ratio (TTM) 0.76

Profitability Ratios Current
Gross Margin (MRQ) 37.74 %
Operating Margin (MRQ) 20.53 %
Net Margin (MRQ) 17.65 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 20.79 %

Management Effectiveness Current
Return On Assets (TTM) 12.88 %
Return On Investment (TTM) 15.75 %
Return On Equity (TTM) 18.51 %
Dividend Yield 0.19 %
Pay out Ratio (TTM) 11.14 %



West Pharmaceutical Services Inc's Segments
Proprietary Products    162.43 % of total Revenue
West Vantage    34.43 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.